Vendor review
TSC Top Supplements China reviews
TSC Top Supplements China reviews from 147 independent lab tests (Retatrutide, Tirzepatide and BPC-157): grade A, purity and fill accuracy. Is TSC Top Supplements China legit? See what its vials showed.
What the lab tests show
147 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Sep 4, 2026 | BPC-157 | 10 mg | Fail | View | |
| Sep 4, 2026 | Tirzepatide | 99.9 % | 19.1 mg of 20 mg (-4 %) | Pass | View |
| Aug 28, 2026 | Retatrutide | 99.8 % | 10.7 mg of 10 mg (7 %) | Pass | View |
| Aug 3, 2026 | Retatrutide | 99.9 % | 4.37 mg of 5 mg (-13 %) | Pass | View |
| Jul 20, 2026 | Retatrutide | 99.9 % | 4.78 mg of 5 mg (-4 %) | Pass | View |
| Jun 22, 2026 | Retatrutide | 99.9 % | 18.2 mg of 20 mg (-9 %) | Pass | View |
| Jun 16, 2026 | Retatrutide | 99.8 % | 28.6 mg of 30 mg (-5 %) | Pass | View |
| May 19, 2026 | Retatrutide | 99.9 % | 25.9 mg of 50 mg (-48 %) | Pass | View |
| May 13, 2026 | Tesamorelin | 99.9 % | 11.5 mg of 10 mg (15 %) | Pass | View |
| May 6, 2026 | GHK-Cu | 99.9 % | 66.7 mg of 50 mg (33 %) | Pass | View |
| May 6, 2026 | TB-500 | 99.4 % | 8.75 mg of 10 mg (-13 %) | Pass | View |
| May 6, 2026 | BPC-157 | 99.9 % | 3.78 mg of 5 mg (-24 %) | Pass | View |
| Apr 30, 2026 | Retatrutide | 99.8 % | 10.7 mg of 10 mg (7 %) | Pass | View |
| Apr 28, 2026 | Retatrutide | 99.9 % | 28.2 mg of 30 mg (-6 %) | Pass | View |
| Apr 28, 2026 | Tirzepatide | 99.9 % | 25.9 mg of 30 mg (-14 %) | Pass | View |
| Apr 27, 2026 | Retatrutide | 10 mg | View | ||
| Apr 26, 2026 | Retatrutide | 99.9 % | 6.07 mg of 10 mg (-39 %) | Pass | View |
| Apr 23, 2026 | Retatrutide | 99.9 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| Apr 23, 2026 | Retatrutide | 99.9 % | 21.1 mg of 20 mg (6 %) | Pass | View |
| Apr 23, 2026 | Tesamorelin | 98.5 % | 15.1 mg of 10 mg (51 %) | Pass | View |
| Mar 21, 2026 | Cagrilintide | 99.7 % | 4.3 mg of 5 mg (-14 %) | Pass | View |
| Mar 19, 2026 | Retatrutide | 99.9 % | 30.7 mg of 30 mg (2 %) | Pass | View |
| Mar 19, 2026 | Retatrutide | 99.9 % | 29.6 mg of 30 mg (-1 %) | Pass | View |
| Mar 19, 2026 | Retatrutide | 99.9 % | 28.4 mg of 30 mg (-5 %) | Pass | View |
| Mar 19, 2026 | Retatrutide | 99.9 % | 9.57 mg of 10 mg (-4 %) | Pass | View |
| Mar 19, 2026 | Retatrutide | 99.9 % | 29.2 mg of 30 mg (-3 %) | Pass | View |
| Mar 17, 2026 | Retatrutide | 99.6 % | 23.9 mg of 20 mg (20 %) | Pass | View |
| Mar 17, 2026 | Tirzepatide | 40 mg | Fail | View | |
| Mar 7, 2026 | Tesamorelin | 99.8 % | 12.6 mg of 10 mg (26 %) | Pass | View |
| Mar 6, 2026 | Retatrutide | 99.9 % | 10.6 mg of 10 mg (6 %) | Pass | View |
| Mar 6, 2026 | Tirzepatide | 99.9 % | 25.6 mg of 30 mg (-15 %) | Pass | View |
| Mar 6, 2026 | Tirzepatide | 99.9 % | 24.1 mg of 30 mg (-20 %) | Pass | View |
| Mar 6, 2026 | Tirzepatide | 99.9 % | 29 mg of 30 mg (-3 %) | Pass | View |
| Mar 4, 2026 | Tirzepatide | 88.09 % | 2.62 mg of 5 mg (-48 %) | Pass | View |
| Mar 4, 2026 | Semaglutide | 99.8 % | 10.8 mg of 10 mg (8 %) | Pass | View |
| Mar 2, 2026 | Retatrutide | 99.9 % | 28.6 mg of 30 mg (-5 %) | Pass | View |
| Mar 2, 2026 | GHK-Cu | 99.9 % | 58.1 mg of 50 mg (16 %) | Pass | View |
| Mar 2, 2026 | Tirzepatide | 99.9 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| Mar 2, 2026 | GHK-Cu | 99.9 % | 106 mg of 100 mg (6 %) | Pass | View |
| Mar 2, 2026 | BPC-157 | 98.3 % | 11.2 mg of 10 mg (12 %) | Pass | View |
| Mar 1, 2026 | Tirzepatide | 99.8 % | 31.2 mg of 30 mg (4 %) | Pass | View |
| Feb 26, 2026 | Retatrutide | 99.9 % | 4.8 mg of 5 mg (-4 %) | Pass | View |
| Feb 20, 2026 | Cagrilintide | 98.46 % | 4.56 mg of 5 mg (-9 %) | Pass | View |
| Feb 18, 2026 | Tirzepatide | 99.16 % | 33.3 mg of 30 mg (11 %) | Pass | View |
| Feb 9, 2026 | TB-500 | 99.09 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Feb 2, 2026 | Tirzepatide | 96.92 % | 10.7 mg of 10 mg (7 %) | Pass | View |
| Jan 29, 2026 | Retatrutide | 99.39 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Jan 29, 2026 | Retatrutide | 99.36 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| Jan 29, 2026 | Retatrutide | 99.28 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| Jan 26, 2026 | Retatrutide | 99.8 % | 22.3 mg of 20 mg (12 %) | Pass | View |
| Jan 26, 2026 | BPC-157 | 98.2 % | 13.7 mg of 10 mg (37 %) | Pass | View |
| Jan 26, 2026 | Tirzepatide | 99.9 % | 64.3 mg of 60 mg (7 %) | Pass | View |
| Jan 19, 2026 | Retatrutide | 99.95 % | 53.5 mg of 60 mg (-11 %) | Pass | View |
| Jan 19, 2026 | Retatrutide | 99.95 % | 8.61 mg of 10 mg (-14 %) | Pass | View |
| Jan 15, 2026 | Retatrutide | 99.8 % | 10.6 mg of 10 mg (6 %) | Pass | View |
| Jan 7, 2026 | Retatrutide | 99.77 % | 10 mg of 10 mg (0 %) | Pass | View |
| Jan 7, 2026 | Retatrutide | 99.31 % | 9.03 mg of 10 mg (-10 %) | Pass | View |
| Jan 1, 2026 | Tirzepatide | 99.8 % | 14.5 mg of 15 mg (-3 %) | Pass | View |
| Jan 1, 2026 | Tirzepatide | 99.9 % | 48.6 mg of 40 mg (22 %) | Pass | View |
| Dec 30, 2025 | Tirzepatide | 99.95 % | 39.9 mg of 40 mg (0 %) | Pass | View |
What TSC Top Supplements China sells
No current listings on record.
About TSC Top Supplements China
Finnrick has tested 147 samples from TSC Top Supplements China across 9 products.